Gilead Plan Kept Up Hepatitis C Drug Prices, Senators Say

[anonymous]

Wow !!!! Tanking worse than Abbvie who's also tanking...Dump both of them ...Govt looking and involved now Time to pull out
Gilead Sciences, Inc.
NASDAQ: GILD - Dec 3 4:02
$101.38 DOWN $3.06 (2.93%)


AbbVie Inc
NYSE: ABBV - Dec 3 4:02
$56.15 Down $1.57 (2.72%)

 

[anonymous]

Right on the nail. Soo true. Yeah, Vpak is pulling in some bucks but sooo far below espoused company expectations to investors and such a pathetically tiny market share for a drug that is over a year post launch. Not good vibes from HCV. I am personally glad to be in Metabolics instead.

You are kidding, right? I would rather be working at a manure factory on Uranus then be in Metabolics. Talk about being in deep shit!!!

 

[anonymous]

this is serious, if anything, Abbvie comes out a winner here. Price gouging the government and public, While Abbvie sells almost exact same product for much less ? this will hurt Gilead it's already reflected in diving GILD stock which was $122 in June Now it's $105 and dropping

Now it's @ $98 and Trumps on board with Bernie sanders and congressional investigation